| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/14/2005 | CN1668316A Anti-spasmodic comprising xenon |
| 09/14/2005 | CN1668315A Anti-spasmodic comprising xenon |
| 09/14/2005 | CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 09/14/2005 | CN1668309A Trimegestone and estrogens for treating post menopausal disorders |
| 09/14/2005 | CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting |
| 09/14/2005 | CN1668298A Antitumor compound and therapeutic uses thereof |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 09/14/2005 | CN1668289A Modafinil pharmaceutical compositions |
| 09/14/2005 | CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea |
| 09/14/2005 | CN1666998A Fucoidan and its use |
| 09/14/2005 | CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof |
| 09/14/2005 | CN1666761A Medicine for quickly and radically treating piles |
| 09/14/2005 | CN1666759A A pharmaceutical composition for treating hypertension, externally applied paste and preparation method thereof |
| 09/14/2005 | CN1666750A Peach blossom oil and its production process |
| 09/14/2005 | CN1666748A Oral formulation of adetphos |
| 09/14/2005 | CN1666739A Application of Silibinin or its salts in preparation of medicine for treating coronary heart disease or strengthening the effect of coronary heart disease treatment |
| 09/14/2005 | CN1218940C Nitric oxide synthase inhibitors |
| 09/14/2005 | CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/14/2005 | CN1218740C Chinese medicine composition for treating apoplexy |
| 09/14/2005 | CN1218732C Preparation process of Qingkailing injection and injection powder |
| 09/14/2005 | CN1218721C Oral Chinese proprietary medicine for treating cerebrovascular and cardiovascular disease |
| 09/14/2005 | CN1218710C Compound traditional Chinese medicine granule for treating CVD |
| 09/14/2005 | CN1218704C Sodium bialginate for injection and its preparation method |
| 09/14/2005 | CN1218701C Use of spirosterol type steroid saponin in preparing medicine for treating cardio-cerebral vascular disease |
| 09/14/2005 | CN1218700C Usage of sulfonylureas derivant in the preparing process of blood vessel embolism disease treating medicine |
| 09/14/2005 | CN1218699C Method for increasing solubility of parabuxinidine-D injection |
| 09/14/2005 | CN1218696C Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 09/14/2005 | CN1218693C Adhesive film agent of Chinese traditional medicine and its preparing method |
| 09/14/2005 | CN1218692C Film coating |
| 09/13/2005 | US6943253 6-phenylpyrrolopyrimidinedione derivatives |
| 09/13/2005 | US6943199 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943186 Administering benzopyrazolyl compound for therapy of sepsis |
| 09/13/2005 | US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis |
| 09/13/2005 | US6943182 Cyclopentabenzofuran derivatives and their use |
| 09/13/2005 | US6943179 Biurethane derivatives |
| 09/13/2005 | US6943176 Heterocyclic derivatives |
| 09/13/2005 | US6943174 6,5-Fused bicyclic heterocycles |
| 09/13/2005 | US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. |
| 09/13/2005 | US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 09/13/2005 | US6943171 For therapy of urological, vascular or pulmonary disorders |
| 09/13/2005 | US6943164 Pharmaceutical solutions of levosimendan |
| 09/13/2005 | US6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones |
| 09/13/2005 | US6943160 Morpholine derivatives as antagonists of orexin receptors |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6943146 Control cell proliferation, cell differentiation; culture product |
| 09/13/2005 | US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders |
| 09/13/2005 | US6943000 Detection of modulator of enzyme activity; obtain cells, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C |
| 09/13/2005 | US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel |
| 09/13/2005 | US6942852 N-terminal modifications of RANTES and methods of use |
| 09/13/2005 | US6942165 Generation of therapeutic microfoam |
| 09/13/2005 | CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 09/13/2005 | CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them |
| 09/13/2005 | CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 09/09/2005 | WO2005082905A1 Bicyclic heterocyclic compound |
| 09/09/2005 | WO2005082887A1 Pyrimidine derivative |
| 09/09/2005 | WO2005082874A1 Novel benzothiazepine and benzothiepine compounds |
| 09/09/2005 | WO2005082860A1 Tetracyclines and their use as calpain inhibitors |
| 09/09/2005 | WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/09/2005 | WO2005082847A1 Bicyclo derivative |
| 09/09/2005 | WO2005082402A1 Preventive/therapeutic agent for organ fibrosis |
| 09/09/2005 | WO2005082391A1 AGONIST TO HUMAN β3 ADRENALINE RECEPTOR |
| 09/09/2005 | WO2005082390A1 Fat accumulation inhibitors |
| 09/09/2005 | WO2005027973A3 Combinations of a vegf receptor inhibitor with other therapeutic agents |
| 09/09/2005 | WO2005011725A3 Anti-angiogenetic agent and its use, in particular in cancer treatment |
| 09/09/2005 | WO2004080482A8 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure |
| 09/09/2005 | WO2004064542A8 Composition for oral administration containing capsaicinoids |
| 09/09/2005 | CA2691611A1 Myocardial perfusion imaging using adenosine receptor agonists |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2557162A1 Coumarin derivative and use thereof |
| 09/09/2005 | CA2557144A1 Non-peptidyl agents with phsp20-like activity, and uses thereof |
| 09/09/2005 | CA2556893A1 Antihypertensive peptides |
| 09/09/2005 | CA2556053A1 Administration of enoxaparin sodium to patients with severe renal impairment |
| 09/09/2005 | CA2555720A1 Isoquinoline derivatives |
| 09/09/2005 | CA2554919A1 Use of methylene amide derivatives in cardiovascular disorders |
| 09/09/2005 | CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/08/2005 | US20050197494 Methods of treating thrombotic diseases with von willebrand factor specific antibodies |
| 09/08/2005 | US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/08/2005 | US20050197372 Use of valsartan or its metabolite to inhibit platelet aggregation |
| 09/08/2005 | US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc. |
| 09/08/2005 | US20050197351 Such as 4-{N-[4-(4-methylbenzenesulfonylamido)benzyl]acetamido}-3-phenyl-2-(piperidine-1-yl)-3,4-dihydroquinazoline; for therapy of angina pectoris, high blood pressure, myocardial disease, pain and epilepsy by blocking the T-type calcium channel |
| 09/08/2005 | US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
| 09/08/2005 | US20050197323 Full or partial glucocorticosteroid replacement therapy for obstructive pulmonary bronchial diseases |
| 09/08/2005 | US20050197295 Modified annexin proteins and methods for preventing thrombosis |
| 09/08/2005 | US20050197284 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 09/08/2005 | US20050196474 Supplement foods and pharmaceuticals |
| 09/08/2005 | US20050196401 Energy-activated targeted cancer therapy |
| 09/08/2005 | DE19956400B4 Therapeutisch wirksame Zusammensetzung, ein Verfahren zu ihrer Herstellung und ihre Verwendung Therapeutically effective composition, a process for their preparation and their use |
| 09/07/2005 | EP1571155A1 Peptides and medicinal compositions containing the same |
| 09/07/2005 | EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 09/07/2005 | EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists |
| 09/07/2005 | EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 09/07/2005 | EP1570871A1 Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury |
| 09/07/2005 | EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor |